A detailed history of Financial Advisory Service, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 5,396 shares of ABT stock, worth $619,244. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,396
Previous 5,236 3.06%
Holding current value
$619,244
Previous $544,000 13.05%
% of portfolio
0.05%
Previous 0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$100.07 - $118.13 $16,011 - $18,900
160 Added 3.06%
5,396 $615,000
Q2 2024

Jul 29, 2024

BUY
$100.73 - $112.44 $3,525 - $3,935
35 Added 0.67%
5,236 $544,000
Q1 2024

Apr 29, 2024

SELL
$109.52 - $120.96 $3,942 - $4,354
-36 Reduced 0.69%
5,201 $591,000
Q4 2023

Jan 23, 2024

BUY
$90.19 - $110.4 $22,276 - $27,268
247 Added 4.95%
5,237 $576,000
Q3 2023

Oct 23, 2023

BUY
$95.53 - $114.62 $476,694 - $571,953
4,990 New
4,990 $483,000
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $3,390 - $3,990
35 Added 0.75%
4,692 $475,000
Q4 2022

Feb 01, 2023

SELL
$95.06 - $111.52 $5,418 - $6,356
-57 Reduced 1.21%
4,657 $511,000
Q3 2022

Oct 20, 2022

SELL
$96.76 - $112.03 $1,838 - $2,128
-19 Reduced 0.4%
4,714 $456,000
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $104,213 - $125,960
1,021 Added 27.51%
4,733 $514,000
Q1 2022

May 04, 2022

SELL
$114.02 - $139.04 $15,734 - $19,187
-138 Reduced 3.58%
3,712 $439,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $3,581 - $4,385
31 Added 0.81%
3,850 $542,000
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $53,663 - $59,367
460 Added 13.69%
3,819 $451,000
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $4,125 - $4,856
39 Added 1.17%
3,359 $389,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $7,945 - $9,360
73 Added 2.25%
3,320 $398,000
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $525 - $572
5 Added 0.15%
3,247 $356,000
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $458 - $556
5 Added 0.15%
3,242 $353,000
Q2 2020

Jul 21, 2020

SELL
$76.57 - $98.0 $1,684 - $2,156
-22 Reduced 0.68%
3,237 $296,000
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $13,506 - $19,749
215 Added 7.06%
3,259 $257,000
Q4 2019

Jan 31, 2020

SELL
$78.51 - $87.4 $8,400 - $9,351
-107 Reduced 3.4%
3,044 $264,000
Q3 2019

Nov 06, 2019

BUY
$81.84 - $88.74 $27,498 - $29,816
336 Added 11.94%
3,151 $264,000
Q2 2019

Jul 25, 2019

SELL
$72.88 - $85.0 $10,713 - $12,495
-147 Reduced 4.96%
2,815 $237,000
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $2,185 - $2,641
33 Added 1.13%
2,962 $237,000
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $23,273 - $26,365
-355 Reduced 10.81%
2,929 $212,000
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $304 - $366
5 Added 0.15%
3,284 $241,000
Q2 2018

Jul 26, 2018

BUY
$57.57 - $63.54 $188,772 - $208,347
3,279 New
3,279 $200,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Advisory Service, Inc. Portfolio

Follow Financial Advisory Service, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.